医学
痰
肺结核
诊断准确性
痰培养
前瞻性队列研究
内科学
金标准(测试)
舌头
病理
作者
Yilin Wang,Junwei Cui,Yuanyuan Li,Miao Wang,Wenge Han,Aimei Liu,Furong Wang,Rongmei Liu,Shuhui Kang,Jianping Zhang,Sihong Zhu,Zhonghai Lai,Wen‐Long Guan,Shengnan Zou,Xiangyu Yin,Qing Jiang,Guangyan Mu,Liying Guan,L. Li,Yu Pang
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2025-01-01
卷期号:65 (1): 2401493-2401493
标识
DOI:10.1183/13993003.01493-2024
摘要
Background Tuberculosis (TB) remains a major cause of infectious disease mortality globally, with significant underdiagnosis perpetuating transmission. Tongue swab analysis has emerged as a promising non-invasive method for pulmonary TB diagnosis. This study evaluates the diagnostic accuracy of the TB-EASY quantitative PCR (qPCR) assay using tongue swab specimens. Methods In this prospective multicentre study, conducted across seven designated TB hospitals in China, 729 participants were included in the analysis. Tongue swabs were tested using the new TB-EASY assay from Hugobiotech, while sputum samples were analysed by Xpert MTB/RIF (Xpert), smear and culture tests. Diagnostic performance was compared to a composite microbiological reference standard (MRS). Results The TB-EASY assay demonstrated high diagnostic accuracy, with sensitivity and specificity of 89.6% and 96.2% compared to sputum Xpert, and 87.4% and 98.0% compared to the MRS. Sensitivity varied by bacterial load, ranging from 100% in high-load cases to 70.4% in very-low-load cases. The assay demonstrated robust performance in diverse epidemiological settings. Conclusions The TB-EASY qPCR assay using tongue swabs offers a reliable, non-invasive diagnostic alternative for pulmonary TB, especially where sputum collection is challenging. Its potential for wider use in high TB burden settings warrants further validation in community-based studies. Limitations include potential overestimation of sensitivity due to the selection of symptomatic patients and the use of sputum Xpert rather than Xpert Ultra. Additionally, the performance in non-sputum-producing patients remains untested, and the cost-effectiveness should be further evaluated to assess the feasibility of its implementation.
科研通智能强力驱动
Strongly Powered by AbleSci AI